Century TherapeuticsIPSC
13F holders, Q4 2025 (December 31)At the end of Q4 2025, 47 institutions reported holding Century Therapeutics Inc. (IPSC) in their 13F filings, down 10 from Q3 2025. 7 opened new positions and 16 sold out. The largest holders were Point72 Asset Management ($5.9M), DAFNA Capital Management LLC ($2.8M) and Vanguard Group Inc. ($2.1M). 4 famous investors held it, including Steve Cohen (0.0% of Point72 Asset Management's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Century Therapeutics Inc.
- CUSIP
- 15673T100
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $7.9M |
| Exits | 16 | $2.4M |
All 13F filers, Q3 2025 → Q4 2025: 10,739,859 shares bought and 6,734,361 shares sold, net +4,005,498 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 47 holders
| Point72 Asset Management | 0.01% | New | 5,961,631 | $5.9M |
| DAFNA Capital Management LLC | 0.65% | Add +63.9% | 2,793,586 | $2.8M |
| Vanguard Group Inc. | 0.00% | No change | 2,103,869 | $2.1M |
| Adage Capital Partners Gp, L.L.C. | 0.00% | New | 1,838,700 | $1.8M |
| Two Sigma Investments, LP | 0.00% | Add +64.1% | 1,495,916 | $1.5M |
| Spruce Street Capital LP | 0.47% | — | 1,421,532 | $1.4M |
| Renaissance Technologies | 0.00% | Reduce -47.8% | 1,349,200 | $1.3M |
| Two Sigma Advisers, LP | 0.00% | Add +47.8% | 1,267,700 | $1.3M |
| Casdin Capital, LLC | 0.08% | No change | 1,228,190 | $1.2M |
| Acadian Asset Management LLC | 0.00% | Add +69.1% | 1,217,103 | $1.2M |
| Syncona Portfolio Ltd | 3.52% | No change | 1,213,056 | $1.2M |
| Millennium Management | 0.00% | Reduce -17.9% | 610,387 | $607K |
| BlackRock, Inc. | 0.00% | Add +0.4% | 601,866 | $599K |
| Superstring Capital Management LP | 0.25% | No change | 462,963 | $461K |
| Geode Capital Management, LLC | 0.00% | Add +2.4% | 456,115 | $454K |
| Gsa Capital Partners LLP | 0.03% | Reduce -44.8% | 333,199 | $331K |
| Citadel Advisors | 0.00% | Reduce -11.5% | 319,457 | $318K |
| UBS Group AG | 0.00% | Add +63550.2% | 214,501 | $213K |
| State Street Corp. | 0.00% | No change | 127,443 | $127K |
| Northern Trust Corp. | 0.00% | Add +56.8% | 105,052 | $105K |
| Raymond James Financial Inc. | 0.00% | No change | 91,323 | $91K |
| Algert Global LLC | 0.00% | New | 76,800 | $76K |
| FMR LLC | 0.00% | Reduce -62.8% | 71,540 | $71K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | Reduce -0.1% | 77,797 | $70K |
| Prudential Financial Inc. | 0.00% | No change | 59,800 | $59K |
| Susquehanna International Group, LLP | 0.00% | Reduce -26.2% | 50,104 | $50K |
| Jane Street Group, LLC | 0.00% | Reduce -23.1% | 45,194 | $45K |
| HarbourVest Partners LLC | 0.02% | No change | 29,018 | $29K |
| Parametrica Management Ltd | 0.04% | No change | 27,840 | $28K |
| XTX Topco Ltd | 0.00% | Reduce -44.4% | 15,333 | $15K |
| Quadrant Private Wealth Management, LLC | 0.00% | No change | 15,286 | $15K |
| Scientech Research LLC | 0.01% | New | 12,355 | $12K |
| Advisors Asset Management, Inc. | 0.00% | Reduce -1.2% | 8,313 | $8K |
| JPMorgan Chase & Co. | 0.00% | Add +93.2% | 3,077 | $3K |
| Simplex Trading, LLC | 0.00% | New | 2,397 | $2K |
| SBI Securities Co., Ltd. | 0.00% | No change | 1,530 | $2K |
| BNP Paribas Financial Markets | 0.00% | Reduce -2.1% | 1,447 | $1K |
| Nisa Investment Advisors, LLC | 0.00% | No change | 883 | $878 |
| Bank of America Corp. | 0.00% | Reduce -12.2% | 525 | $522 |
| Mark Sheptoff Financial Planning, LLC | 0.00% | No change | 500 | $497 |
| Arax Advisory Partners | 0.00% | No change | 99 | $98 |
| Wells Fargo & Company | 0.00% | New | 40 | $40 |
| Optiver Holding B.V. | 0.00% | No change | 32 | $32 |
| Barclays PLC | 0.00% | No change | 1 | $1 |
| Citigroup Inc. | 0.00% | Reduce -100.0% | 1 | $1 |
| Smartleaf Asset Management LLC | 0.00% | New | 1 | $1 |
| Royal Bank of Canada | 0.00% | Reduce -2.8% | 69 | $0 |
"% of holder's portfolio" is IPSC's weight in each manager's 13F, not the share of Century Therapeutics Inc. the manager owns.